Videos
Ignacio Núñez, COO, CellReady, Discusses Sustainability in Cell Therapy at ISCT 2024
Ignacio Nunez, COO of CellReady, discusses the importance of sustainability in cell and gene therapy manufacturing at ISCT 2024.
Videos
Ignacio Núñez, COO, CellReady, Discusses Current Projects at ASGCT 2024
Ignacio Nunez, COO of CellReady, discusses current projects and what the future holds during ASGCT 2024.
Videos
ISCT 2024: Redefining Sustainability in CGT, Ensuring Patient Affordability and Accessibility
Leading industry experts discuss critical strategies to make life-changing treatments more accessible and affordable for patients during ISCT 2024. Hear from top executives at Germfree, Cellular Origins, and CellReady as they discuss innovative solutions to overcome industry challenges. Moderated by ScaleReady.
Videos
Ignacio Núñez, COO, CellReady, Discusses Partnership with ScaleReady at ISCT 2024
Rizwan Chaudrey spoke with Ignacio Núñez, COO, CellReady, at ISCT 2024 about the company, its relationship with ScaleReady, what they are showcasing tat ISCT and what makes them unique.
Videos
Multiply Labs and Wilson Wolf Collaborate to Automate G-Rex for Cell Therapy Manufacturing
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Wilson Wolf, an innovative leader in cell and gene-modified cell (CGT) manufacturing technology, today announced a collaboration around the automation of Wilson Wolf’s G-Rex® bioreactors.
Videos
Future of T Cell Manufacturing using G-Rex Closed-system Bioreactors
This video animation demonstrates a vision toward the industrialization and automation of T cell therapy manufacturing using G-Rex Bioreactors.
Video was created by Wilson Wolf Manufacturing Corporation.
Video was created by Wilson Wolf Manufacturing Corporation.
Videos
G-Rex – Revolutionizing Cell Therapy Manufacturing
In this video you will learn how G-Rex bioreactors solve the limitations of flask and bag-based cell therapy manufacturing. By providing cells with uninterrupted access to oxygen and nutrients, the G-Rex cell culture device is the only accessible cell expansion technology that linearly scales to meet the demands of cell therapy manufacturers.
Videos
On Demand Symposium: Defining Intelligent Scale-up and Scale-out
In this recorded symposium, cell therapy manufacturing leaders speak about defining and planning for intelligent commercial scale up and scale out. Recorded at ISCT 2021.
Videos
Evolution of Tumor-specific T Cell Production
This video features Juan Vera, Chief Development Officer at Marker Therapeutics, discussing how Marker used G-Rex Bioreactors and the Lovo Cell Processing System to evolve and simplify manufacturing of its multiple tumor-associated antigen (MultiTAA) T cell therapy in anticipation of commercialization.
This ScaleReady-sponsored seminar originally aired at the CAR-TCR Virtual 2021 Conference (Hanson Wade) on September 1st, 2021.
This ScaleReady-sponsored seminar originally aired at the CAR-TCR Virtual 2021 Conference (Hanson Wade) on September 1st, 2021.